Aktis Oncology, Inc. AKTS
- [225Ac]Ac-AKY-2519 — Prostate Cancer Phase 1
- [225Ac]Ac-AKY-2519 — Non-Small Cell Lung Cancer Phase 1
- [225Ac]Ac-AKY-2519 Preclinical
B7-H3 (1 companies · 3 programs)
Companies with an active program directed at B7-H3.
Companies with an active program directed at B7-H3.